An underground market for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Experimental Treatment Gaining Traction Via Social Media
Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these accounts directly for supplier links, while also receiving discount codes.
Thriving Trade on Messaging Platforms
Additionally, a robust trade exists on Telegram, where groups with numerous of participants share “before and after” images, injection guides and assertions of next-day UK delivery. Vendors market the drug there before directing customers to WhatsApp for purchases.
Understanding The Experimental Drug
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.
Medical Experts Voice Concerns
Nevertheless, physicians and chemists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could result in users administering substances of uncertain source.
Several experts stated the popularity for the experimental drug could be connected to the rising price of licensed slimming treatments such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations.
Some content creators try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate medicines, advertising, and consumer laws, risking fines, legal action or prison.
Service Response and Content Elimination
According to the social media company, the service has taken down violative content and prohibited related keywords and search suggestions. The company said it was committed to keeping the service secure and allocating resources in enhancing compliance measures.
Online Trading Operations
Research also found communities with up to 9,000 members marketing retatrutide using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up groups with thousands of users, filled with images of slimming results, positive reviews and detailed instructions for mixing or administering at residence.
After moments of entering one community, a vendor shared contact information, where the majority of transactions occur. The seller sent an instruction manual and guaranteed shipping within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about weight, medical conditions or previous experience.
Product Information and Pricing
Inside these communities, messages show black plastic parcels with postal service labels, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at home with sterile water, or pre-filled injectors typically sold at £160 for 20 milligrams. When questioned how long a injector should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A representative for the messaging service said it actively monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are administering substances they can’t verify. Even if the research behind retatrutide is valid, these digital versions may not contain what they claim,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor connected the increase in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are using online platforms. But fake treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.
Her staff has previously encountered individuals harmed by self-injection from unverified sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a company investigational substance not yet approved … may expose users to possibly serious medical dangers”.
